Physician profile
Glenn Weaver
NPI 1063463495
$2,908.56
in general payments reported to CMS, 2019-2025
18 companies · $608 in 2025
The $608 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $125 · 2021: $461 · 2022: $497 · 2023: $460 · 2024: $223 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,290.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $339.64 | 2021-2024 | |
| Boston Scientific Corporation | $260.67 | 2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $257.20 | 2023-2025 | Prestige LP Cervical Disc System, Catalyft Pl Expandable Interbody System |
| Phathom Pharmaceuticals, INC. | $250.64 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $238.23 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $187.33 | 2019-2023 | Spravato |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Merck Sharp & Dohme LLC | $125.00 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Abbvie INC. | $124.74 | 2022 | |
| Amarin Pharma, INC. | $121.97 | 2019 | |
| Daiichi Sankyo INC. | $121.04 | 2022 | |
| Gilead Sciences, INC. | $119.70 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.45 | 2023 | |
| Axsome Therapeutics, INC. | $102.06 | 2025 | Sunosi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $100.57 | 2023 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $99.45 | 2019 | |
| Alkermes, INC. | $94.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.